CEACAM5 and carcinoma: For instance, carcinoembryonic antigen (CEA), prostate-specific antigen (PSA), carcinoma antigens (CA), circulating tumor DNA (ctDNA), and circulating tumor cells (CTCs) as biomarkers are now widely applied in the clinical practices [3].